Our mission

We are committed to creating safe, cytokine-based agonists capable of overcoming tumor immune suppression and reawaken the patient's immune system, enabling them to identify and eradicate cancer cells. This core principle is reflected in our name, Immunowake.

Our Platform

Cytokines play a central role in coordinating immune cell activation, proliferation, and communication, which makes them powerful tools for cancer immunotherapy.

Clinical use of cytokines has been limited due to severe dose-limiting toxicities such as inflammation, vascular leakage, and organ damage. These safety concerns highlight the need for targeted or localized delivery strategies to fully harness cytokines' anti tumor effects.

Learn more

Our Pipeline

Our team leverages decades of experience in drug discovery and development to create a robust pipeline of immunocytokines designed to treat both cancer and autoimmune diseases.
Learn more